|
⚲
|
| Keyboard |
| David Cash | |
|---|---|
| Firm | |
| Address | c/o Osteal Therapeutics, Inc 4835 Lyndon B Johnson Fwy Ste 635 Dallas, TX 75244 |
| Source |
| Associated Funds | Form D | Role | 2011 - 2026 | Raised | AUM |
|---|---|---|---|---|---|
| Osteal Therapeutics Inc | 021-563186 | Director | 15.6 M of 26.7 M |
||
| Brightspec Inc | 021-545429 | Director | 3.9 M of 11.1 M |
||
| Osteal Therapeutics Inc | 021-515264 | Director | 50.0 M of 50.0 M |
||
| Osteal Therapeutics Inc | 021-491921 | Director | 22.3 M of 23.0 M |
||
| Brightspec Inc | 021-467869 | Director | 7.5 M of 15.0 M |
||
| Osteal Therapeutics Inc | 021-427231 | Director | 30.2 M of 32.4 M |
||
| Brightspec Inc | 021-419063 | Director | 0.8 M of 1.5 M |
||
| Osteal Therapeutics Inc | 021-381333 | Director | 2.0 M of 2.0 M |
||
| Brightspec Inc | 021-334704 | Director | 2.1 M of 2.7 M |
||
| Medvest Fund II LP | 021-283041 | Executive Officer | of 25.0 M |
||
| Providence Medical Technology Inc | 021-262017 | Director | 3.7 M of 8.0 M |
||
| Medvest Fund LP | 021-199509 | Promoter | 2.0 M of 8.0 M |
||
| Digital Risk LLC | 021-81819 | Executive Officer | 5.0 M of 7.5 M |
||